These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6311580)

  • 1. Antinociceptive studies of the optical isomers of N-allylnormetazocine (SKF 10,047).
    Aceto MD; May EL
    Eur J Pharmacol; 1983 Jul; 91(2-3):267-72. PubMed ID: 6311580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
    J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys.
    Katz JL; Spealman RD; Clark RD
    J Pharmacol Exp Ther; 1985 Feb; 232(2):452-61. PubMed ID: 3968644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of a sigma receptor agonist in the rat: role of monoamine systems.
    Steinfels GF; Tam SW; Cook L
    Eur J Pharmacol; 1987 Sep; 141(1):163-6. PubMed ID: 2822445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
    Halberstadt AL; Hyun J; Ruderman MA; Powell SB
    Pharmacol Biochem Behav; 2016 Sep; 148():69-75. PubMed ID: 27236030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma receptors mediated the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties.
    Khazan N; Young GA; El-Fakany EE; Hong O; Calligaro D
    Neuropharmacology; 1984 Aug; 23(8):983-7. PubMed ID: 6090969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the discriminative stimulus effect of an enkephalin analog, EK-399, in the rat].
    Nishida N; Yasuhara Y; Chiba S
    Nihon Yakurigaku Zasshi; 1991 Jun; 97(6):361-9. PubMed ID: 1651892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats.
    Shannon HE
    Eur J Pharmacol; 1982 Oct; 84(3-4):225-8. PubMed ID: 7173321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of N-allylnormetazocine on electric shock titration in squirrel monkeys.
    Slifer BL; Dykstra LA
    Alcohol Drug Res; 1987; 7(4):217-24. PubMed ID: 3030339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
    Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent pA2 estimates for an antinociceptive receptor.
    Parale MP; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):59-67. PubMed ID: 2862851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice.
    Suh HH; Fujimoto JM; Tseng LL
    Eur J Pharmacol; 1989 Sep; 168(1):61-70. PubMed ID: 2531093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution.
    Compton DR; Bagley RB; Katzen JS; Martin BR
    Life Sci; 1987 Jun; 40(22):2195-206. PubMed ID: 3035304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-allylnormetazocine: hemodynamic actions and inhibition of leucine-enkephalin hemodynamic activity in conscious dogs.
    Given MB; Sander GE; Lowe RF; Giles TD
    J Pharmacol Exp Ther; 1988 Dec; 247(3):850-6. PubMed ID: 3204519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive activity of N-(4-hydroxyphenacetyl)-4-aminoclonidine, a novel analog of clonidine: role of opioid receptors and alpha-adrenoceptors.
    Hynes MD; Atlas D; Ruffolo RR
    Pharmacol Biochem Behav; 1983 Nov; 19(5):879-82. PubMed ID: 6316375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L; Wong EH; Kesingland AC; Tricklebank MD
    Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874.
    Bhalla S; Rapolaviciute V; Gulati A
    Eur J Pharmacol; 2011 Jan; 651(1-3):109-21. PubMed ID: 21114998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.